Emergence of piperacillin/tazobactam-resistant Escherichia coli

Intensive Care Med. 2000 Oct;26(10):1584. doi: 10.1007/s001340000659.
No abstract available

Publication types

  • Letter

MeSH terms

  • Communicable Diseases, Emerging / drug therapy
  • Communicable Diseases, Emerging / epidemiology
  • Communicable Diseases, Emerging / microbiology*
  • Cross Infection / drug therapy
  • Cross Infection / epidemiology
  • Cross Infection / microbiology*
  • Drug Resistance, Microbial
  • Drug Therapy, Combination*
  • Escherichia coli Infections / drug therapy
  • Escherichia coli Infections / epidemiology
  • Escherichia coli Infections / microbiology*
  • France / epidemiology
  • Humans
  • Infection Control
  • Intensive Care Units
  • Patient Selection
  • Penicillanic Acid* / analogs & derivatives*
  • Penicillins*
  • Piperacillin*
  • Tazobactam
  • beta-Lactamase Inhibitors*

Substances

  • Penicillins
  • beta-Lactamase Inhibitors
  • Penicillanic Acid
  • Tazobactam
  • Piperacillin